Abstract
Juvenile idiopathic arthritis (JIA) is in a majority of the cases of self-limiting, and sometimes even a self-remitting, disease. A growing amount of data suggests that active T cell regulation determines, at least partly, the clinical outcome of JIA. In experimental models of arthritis, a group of highly conserved microbial proteins, heat shock proteins (hsps), can be used to effectively prevent and treat arthritis. This protection is mediated through the induction of cross-reactive T cell responses to self-hsps. In JIA, naturally occurring T cell immune responses to hsps are associated with disease remission in restricted oligoarticular JIA. Moreover, those responses are associated with the induction of T cells with a regulatory phenotype. Taken together, these data imply that immune modulation with hsps can be an effective way to restore natural occurring T cell responses, and, thus, treat JIA and rheumatoid arthritis.
Similar content being viewed by others
References and Recommended Reading
Woo P, Wedderburn LR: Juvenile chronic arthritis. Lancet 1998, 351:969–973.
Kulas DT, Schanberg L:Juvenile idiopathic arthritis. Curr Opin Rheumatol 2001, 13:392–398.
Petty RE: Classification of childhood arthritis: a work in progress. Baillieres Clin Rheumatol 1998, 12:181–190.
Glass DN, Giannini EH:Juvenile rheumatoid arthritis as a complex genetic trait. Arthritis Rheum 1999, 42:2261–2268. s is an excellent review describing the interaction between several immunogenetic factors, including major histocompatibility complex polymorphisms, that may lead to clinical susceptibility of disease
Grom AA, Hirsch R:T-cell and T-cell receptor abnormalities in the immunopathogenesis of juvenile rheumatoid arthritis. Curr Opin Rheumatol 2000, 12:420–424.
Wedderburn LR, Robinson N, Patel A, et al.: Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis. Arthritis Rheum 2000, 43:765–774. This study shows that synovial T cells from patients with JIA express high levels of chemokine receptors CCR5 and CXCR3 and have a bias towards a Th1 cytokine profile. The authors show that this is because of a specific recruitment of those cells towards the inflamed synovium.
Shevach EM:Regulatory T cells in autoimmunity. Ann Rev Immunol 2001, 18:423–449.
Prakken ABJ, van Hoeij MJ, Kuis W, et al.: T-cell reactivity to human hsp60 in oligoarticular juvenile chronic arthritis is associated with a favorable prognosis and the generation of regulatory cytokines in the inflamed joint. Immunol Lett 1997, 57:139–142.
Murray KJ, Grom AA, Thompson SD, et al.:Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: prominence of interleukin 4 in restricted disease. J Rheumatol 1998, 25:1388–1398.
Thompson SD, Luyrink LK, Graham TB, et al.: Chemokine receptor CCR4 on CD4+ T cells in juvenile rheumatoid arthritis synovial fluid defines a subset of cells with increased IL-4:IFN-gamma mRNA ratios. J Immunol 2001, 166:6899–6906. This elegant study shows an accumulation of CCR4-positive CD4- positive T cells in the inflamed joint of patients with JIA. The authors show that these cells have anti-inflammatory capacities, and suggest that they play a role in controlling inflammation during the early years of disease.
Taams LS, Smith J, Rustin MH, et al.: Human anergic/ suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population. Eur J Immunol 2001, 31:1122–1131. Important study, being the first proof of the presence of suppressive CD4/CD25 double positive cells in humans
Pugh MT, Southwood T, Hill Gaston JS: The role of infection in juvenile chronic arthritis. Br J Rheumatol 1993, 32:838–844.
Chen J, Field JA, Glickstein L, et al.: Association of antibiotic treatment-resistant Lyme arthritis with T cell responses to dominant epitopes of outer surface protein A of Borrelia burgdorferi. Arthritis Rheum 1999, 42:1813–1822.
Albani S, Carson DA: A multistep molecular mimicry hypothesis for the pathogenesis of rheumatoid arthritis. Immunol Today 1996, 17:466–470.
Benoist C, Mathis D: Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat Immunol 2001, 2:797–801. This excellent review discusses the concept and molecular mechanisms (in experimental models) of antigenic mimicry at the T cell level leading to autoimmunity. The authors conclude that evidence that this type of antigenic mimicry actually leads to autoimmunity is not convincing at all.
Gaston JSH: Heat shock proteins and arthritis: new readers start here. Autoimmunity 1997, 26:33–42.
Van Eden W, van der Zee R, Paul AGA, et al.:Do heat shock proteins control the balance of T-cell regulation in inflammatory diseases? Immunol Today 1998, 19:303–307.
Van Eden W, Thole JER, van der Zee R, et al.:Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature 1988, 331:171–173.
Ragno S, Winrow VR, Mascagni P, et al.:A synthetic 10-kD heatshock protein (hsp10) from Mycobacterium tuberculosis modulates adjuvant arthritis. Clin Exp Immunol 1996, 103:384–390.
Kingston AE, Hicks CA, Colston MJ, Billingham MEJ: A 71-kD heat shock protein (hsp) from Mycobacterium tuberculosis has modulatory effects on experimental rat arthritis. Clin Exp Immunol 1996, 103:77–82.
Wendling U, Paul L, van der Zee R, et al.: A conserved mycobacterial heat shock protein (hsp) 70 sequence prevents adjuvant arthritis upon nasal administration and induces IL-10- producing T cells that cross-react with the mammalian self-hsp70 homologue. J Immunol 2000, 164:2711–2717.
Anderton SM, van der Zee R, Noordzij A, Van Eden W: Differential mycobacterial 65-kDa heat shock protein T cell epitope recognition after Adjuvant Arthritis-inducing or protective immunization protocols. J Immunol 1994, 152:3656–3664.
Anderton SM, van der Zee R, Prakken ABJ, et al.:Activation of T-cells recognizing self 60 kDa heat shock protein can protect against experimental arthritis. J Exp Med 1995, 181:943–952.
Cohen IR, Young DB:Autoimmunity, microbial immunity and the immunological homunculus. Immunol Today 1991, 12:105–110.
Prakken BJ, Wendling U, van der Zee R, et al.:Induction of IL-10 and inhibition of experimental arthritis are specific features of microbial heat shock proteins that are absent for other evolutionarily conserved immunodominant proteins. J Immunol 2001, 167:4147–4153. Study showing the unique capacity of hsps to protect in arthritis and their capacity to induce IL-10 production.
Van Eden W, Wendling U, Paul AG, et al.:Arthritis protective regulatory potential of self-hsp cross-reactive T cells. Cell Stress Chaperones 2000, 5:452–457.
Abulafia-Lapid R, Elias D, Raz I, et al.:T cell proliferative responses of type 1 Diabetes patients and healthy individuals to human hsp60 and its peptides. J Autoimmunity 1999, 12:121–129.
Boog CJP, de Graeff-Meeder ER, Lucassen MA, et al.: Two monoclonal antibodies generated against human hsp60 show reactivity with synovial membranes of patients with juvenile chronic arthritis. J Exp Med 1992, 175:1805–1810.
de Graeff-Meeder ER, Rijkers GT, Voorhorst-Ogink MM, et al.: Antibodies to human hsp60 in patients with juvenile chronic arthritis, diabetes mellitus and cystic fibrosis. Pediatr Res 1993, 34:424–428.
de Graeff-Meeder ER, Voorhorst M, Van Eden W, et al.: Antibodies to the mycobacterial 65-kD heat shock protein are reactive with synovial tissue of adjuvant arthritic rats and patients with rheumatoid arthritis and osteoarthritis. Am J Path 1990, 137:1013–1017.
Life P, Hassel A, Williams K, et al.:Responses to gram negative enteric bacterial antigens by synovial T cells from patients with juvenile chronic arthritis: recognition of heat shock protein hsp60. J Rheumatol 1993, 20:1388–1396.
Prakken ABJ, Van Eden W, Rijkers GT, et al.:Autoreactivity to human heat-shock protein 60 predicts disease remission in oligoarticular juvenile rheumatoid arthritis. Arthritis Rheum 1996, 39:1826–1832.
Albani S, Ravelli A, Massa M, et al.:Immune responses to the Escherichia coli dnaJ heat shock protein in juvenile rheumatoid arthritis and their correlation with disease activity. J Pediatr 1994, 124:561–565.
Prakken BJ, Carson DA, Albani S:T cell repertoire formation and molecular mimicry in rheumatoid arthritis. Curr Dir Autoimmun 2001, 3:51–63. Review describing the formation of the T cell repertoire in relationship to the concept of molecular mimicry in RA.
de Graeff-Meeder ER, Van Eden W, Rijkers GT, et al.: Juvenile chronic arthritis: T cell reactivity to human HSP60 in patients with a favorable course of arthritis. J Clin Invest 1995, 95:934–940.
Prakken ABJ, Van Eden W, Rijkers GT, et al.:Autoreactivity to human heat-shock protein 60 predicts disease remission in oligoarticular juvenile rheumatoid arthritis. Arthritis Rheum 1996, 39:1826–1832.
Del Prete G, De Carli M, D’Elios MM, et al.: CD30-mediated signaling promotes the development of human T helper type2-like T cells. J Exp Med 1995, 182:1655–1661.
van Roon JAG, Van Eden W, van Roy JLAM, et al.: Stimulation of suppressive T cell responses by human but not bacterial 60-kD heat-shock protein in synovial fluid of patients with rheumatoid arthritis. J Clin Invest 1997, 100:459–463.
Ronaghy A, Prakken BJ, Takabayashi K, et al.: Immunostimulatory DNA sequences influence the course of adjuvant arthritis. J Immunol 2002, 168:51–56.
Taggart DP, Bakkenist CJ, Biddolph SC, et al.: Induction of myocardial heat shock protein 70 during cardiac surgery. J Pathol 1997, 182:362–366.
Trost SU, Omens JH, Karlon WJ, et al.: Protection against myocardial dysfunction after a brief ischemic period in transgenic mice expressing inducible heat shock protein 70. J Clin Invest 1998, 101:855–862.
Hohlfeld R, Engel AG: Expression of 65-kd heat shock proteins in the inflammatory myopathies. Ann Neurol 1992, 32:821–823.
Khoury SJ, Hancock WW, Weiner HL:Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor b, interleukin 4 and prostaglandin E expression in the brain. J Exp Med 1992, 176:1355–1364.
Weiner HL, Friedman A, Miller A, et al.:Oral tolerance: Immunologic mechanisms and treatment of animal and human organ specific autoimmune diseases by oral administration of autoantigens. Ann Rev Immunol 1994, 12:809–837.
Metzler B, Wraith DC:Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int Immunol 1993, 5:1159–1165.
Prakken BJ, van der Zee R, Anderton SM, et al.:Peptide induced nasal tolerance for a mycobacterial hsp60 T cell epitope in rats suppresses both adjuvant arthritis and non-microbially induced experimental arthritis. Proc Natl Acad Sci U S A 1997, 94:3284–3289.
Prakken B, Wauben M, van Kooten P, et al.: Nasal administration of arthritis-related T cell epitopes of heat shock protein 60 as a promising way for immunotherapy in chronic arthritis. Biotherapy 1998, 10:205–211.
Prakken BJ, Roord STA, van Kooten PJS, et al.: Inhibition of adjuvant arthritis by IL-10 driven regulatory cells induced via nasal administration of a peptide analogue of an arthritis related hsp60 T cell epitope. Arthritis Rheum 2002, 46:1937–1946.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Prakken, B., Kuis, W., Eden, W.v. et al. Heat shock proteins in juvenile idiopathic arthritis: Keys for understanding remitting arthritis and candidate antigens for immune therapy. Curr Rheumatol Rep 4, 466–473 (2002). https://doi.org/10.1007/s11926-002-0052-7
Issue Date:
DOI: https://doi.org/10.1007/s11926-002-0052-7